There were no generic alternatives to a lifesaving drug when Shkreli jacked up its price by more than $700 per pill in 2015.
The Supreme Court on Monday rejected an appeal from Martin Shkreli, who was once dubbed “Pharma Bro” after jacking up the ...
The U.S. Supreme Court declined on Monday to hear former pharmaceutical company CEO Martin Shkreli's challenge to a $64.6 ...
Martin Shkreli in 2022 was banned from the pharmaceutical industry and ordered to disgorge profits earned from raising the ...
Former pharmaceutical executive Martin Shkreli pauses while speaking to the press after the jury issued a verdict in his case ...
In a significant legal development, the U.S. Supreme Court has denied Martin Shkreli’s appeal to overturn a $64.6 million ...
The judge cited Shkreli’s “particularly heartless and coercive” tactics in monopolizing Daraprim and keeping generic rivals ...
The former pharmaceutical executive sought to appeal a $64.6 million judgement issued against him for inflating drug cost and ...
Mr. Shkreli was convicted of defrauding investors and sentenced in 2018 to seven years in prison; he served about five years. A federal judge also banned Mr. Shkreli from the pharmaceutical industry ...